Skip to main content
. 2014 Dec 26;17(4):339–343. doi: 10.4048/jbc.2014.17.4.339

Table 4.

Coxregression analysis for overall survival

graphic file with name jbc-17-339-i004.jpg

HR=hazard ratio; CI=confidential interval; ECOG=Eastern Cooperative Oncology Group; PS=performance status; ER=estrogen receptor; PR=progesterone receptor; HER2=human epidermal growth factor receptor 2; DDFI=distant disease-free interval; TTGP=time interval from the diagnosis of metastasis to gemcitabine and cisplatin therapy.